Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes (DKDPilot)
|ClinicalTrials.gov Identifier: NCT01377688|
Recruitment Status : Completed
First Posted : June 21, 2011
Last Update Posted : June 3, 2014
We propose to pilot a telehealth approach to evaluate components of risk communication by:
- Providing personalized tailored patient feedback to help initiate and maintain specific diabetic kidney disease (DKD)-related behaviors (e.g., medication adherence, weight, exercise, diet, smoking cessation) to reduce their risks.
- Evaluating how this feedback can be incorporated into clinical care by examining 6 month patient outcomes.
Specific Aims are:
- To evaluate the feasibility and acceptability of providing both patients and their provider feedback on individuals' DKD risk via the telehealth intervention and incorporating it into regular clinical practice.
- If improvements in outcomes are found, to estimate the cost of the program in terms of the patient, provider, and overall costs of implementing the program.
|Condition or disease|
|Diabetic Kidney Disease|
|Study Type :||Observational|
|Actual Enrollment :||19 participants|
|Official Title:||Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes|
|Study Start Date :||October 2011|
|Primary Completion Date :||April 2014|
|Study Completion Date :||May 2014|
Diabetics with PKD
Diagnoses of diabetes type 2 with progressive kidney disease (slope of eGFR decline between -15 to -3 ml/min/1.73m2 per year, estimated by calculating an eGFR for each creatinine using the 4-variable Modification of Diet in Renal Disease Study [MDRD] equation and conducting a simple ordinary least squares regression from these values to evaluate changes over time to derive each individuals' slope of eGFR, annualized using test dates)
- Blood pressure and /or Estimated Glomerular Filtration Rate (eGFR) [ Time Frame: 6 months ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01377688
|United States, North Carolina|
|Duke University Health System|
|Durham, North Carolina, United States, 27705|
|Principal Investigator:||Hayden B Bosworth, PhD||Duke Universtiy Medical Center|